• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.肝癌的发生需要 CD44 增强的生长因子信号抑制 p53。
Cancer Cell. 2018 Jun 11;33(6):1061-1077.e6. doi: 10.1016/j.ccell.2018.05.003.
2
RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.RBM38 通过稳定肝癌中的 p53-mdm2 循环功能发挥肿瘤抑制作用。
J Exp Clin Cancer Res. 2018 Sep 3;37(1):212. doi: 10.1186/s13046-018-0852-x.
3
Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis.组蛋白甲基转移酶 G9a 的抑制通过使 DNA 损伤的肝细胞对 p53 诱导的细胞凋亡敏感来减弱肝癌的发生。
Cell Death Dis. 2021 Jan 19;12(1):99. doi: 10.1038/s41419-020-03381-1.
4
Sesn3 deficiency promotes carcinogen-induced hepatocellular carcinoma via regulation of the hedgehog pathway.Sesn3 缺乏通过调控 hedgehog 通路促进致癌物诱导的肝细胞癌。
Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2685-2693. doi: 10.1016/j.bbadis.2019.07.011. Epub 2019 Jul 24.
5
MDM2-p53 pathway in hepatocellular carcinoma.肝细胞癌中的MDM2-p53信号通路
Cancer Res. 2014 Dec 15;74(24):7161-7. doi: 10.1158/0008-5472.CAN-14-1446. Epub 2014 Dec 4.
6
The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.肝癌干细胞中的骨桥蛋白-CD44 轴调节 IFN 信号和 HCV 复制。
Sci Rep. 2018 Sep 3;8(1):13143. doi: 10.1038/s41598-018-31421-6.
7
Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.CD44(标准型和变异型异构体)在肝细胞癌中的蛋白表达:与肿瘤分级、临床病理参数、p53表达及患者生存率的关系
J Hepatol. 2000 Jan;32(1):78-84. doi: 10.1016/s0168-8278(00)80192-0.
8
Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.活化诱导的胞苷脱氨酶在肝癌发生过程中在人肝细胞中的表达。
Int J Cancer. 2007 Feb 1;120(3):469-76. doi: 10.1002/ijc.22292.
9
Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.p53 的诱导使 ATM 缺陷型小鼠对肝癌发生产生抗性。
Gastroenterology. 2010 Mar;138(3):1155-65.e1-2. doi: 10.1053/j.gastro.2009.11.008. Epub 2009 Nov 14.
10
The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.在遗传毒性实验模型中,p27(Kip1)对细胞死亡和增殖的抑制作用可将DNA损伤降至最低。
Int J Cancer. 2009 Nov 15;125(10):2270-80. doi: 10.1002/ijc.24621.

引用本文的文献

1
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma.全面的肿瘤免疫分析揭示了肉瘤样肾细胞癌中矛盾免疫敏感性的介质。
Cancer Cell. 2025 Jul 23. doi: 10.1016/j.ccell.2025.07.010.
2
Inflammation in MASLD progression and cancer.非酒精性脂肪性肝病进展与癌症中的炎症
JHEP Rep. 2025 Apr 2;7(8):101414. doi: 10.1016/j.jhepr.2025.101414. eCollection 2025 Aug.
3
Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets.透明质酸酶:结构、作用机制、疾病及治疗靶点
Mol Biomed. 2025 Jul 12;6(1):50. doi: 10.1186/s43556-025-00299-y.
4
AKT and DUBs: a bidirectional relationship.AKT与去泛素化酶:一种双向关系。
Cell Mol Biol Lett. 2025 Jul 7;30(1):77. doi: 10.1186/s11658-025-00753-3.
5
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer.自我扩增的NRF2-EZH2表观遗传环将KRAS启动的祖细胞转化为侵袭性胰腺癌。
Nat Cancer. 2025 Jun 30. doi: 10.1038/s43018-025-01003-3.
6
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation.在遗传性乳头状肾细胞癌中鉴定出的具有激活型N叶突变的MET变体仍然需要配体刺激。
Mol Oncol. 2025 Feb 20. doi: 10.1002/1878-0261.13806.
7
Role of Liquid Biopsy in Oral Premalignant and Malignant Lesions: Correlation with CD24 and CD44 Expression in Early Diagnosis of Oral Cancer.液体活检在口腔癌前病变和恶性病变中的作用:与CD24和CD44表达的相关性在口腔癌早期诊断中的应用
J Maxillofac Oral Surg. 2025 Feb;24(1):207-212. doi: 10.1007/s12663-024-02398-9. Epub 2024 Dec 11.
8
Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.用于三阴性乳腺癌化学/光/免疫治疗的时空可控活性氧响应型喜树碱纳米炸弹
J Nanobiotechnology. 2024 Dec 27;22(1):798. doi: 10.1186/s12951-024-03050-x.
9
Molecular and immune landscape of hepatocellular carcinoma for therapeutic development.用于治疗开发的肝细胞癌的分子和免疫格局
J Liver Cancer. 2025 Mar;25(1):9-18. doi: 10.17998/jlc.2024.12.02. Epub 2024 Dec 6.
10
The dual role of autophagy in suppressing and promoting hepatocellular carcinoma.自噬在抑制和促进肝细胞癌中的双重作用。
Front Cell Dev Biol. 2024 Oct 11;12:1472574. doi: 10.3389/fcell.2024.1472574. eCollection 2024.

本文引用的文献

1
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.炎症诱导的IgA+细胞破坏抗肝癌免疫。
Nature. 2017 Nov 16;551(7680):340-345. doi: 10.1038/nature24302. Epub 2017 Nov 8.
2
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver.单细胞空间重建揭示了哺乳动物肝脏中的全局分工。
Nature. 2017 Feb 16;542(7641):352-356. doi: 10.1038/nature21065. Epub 2017 Feb 6.
3
IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice.白细胞介素 6 转导信号对于小鼠肝细胞癌的发展是必不可少的。
Hepatology. 2017 Jan;65(1):89-103. doi: 10.1002/hep.28874. Epub 2016 Nov 22.
4
Tumor-Suppressor Functions of the TP53 Pathway.TP53 通路的肿瘤抑制功能
Cold Spring Harb Perspect Med. 2016 May 2;6(5):a026062. doi: 10.1101/cshperspect.a026062.
5
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer.混合性门周肝细胞可使受损肝脏再生而不引发癌症。
Cell. 2015 Aug 13;162(4):766-79. doi: 10.1016/j.cell.2015.07.026.
6
EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation.在肝细胞癌形成过程中,表皮生长因子受体(EGFR)在肝脏巨噬细胞中具有促进肿瘤的作用。
Nat Cell Biol. 2014 Oct;16(10):972-7. doi: 10.1038/ncb3031. Epub 2014 Aug 31.
7
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis.TAK1介导的自噬和脂肪酸氧化可预防肝脂肪变性和肿瘤发生。
J Clin Invest. 2014 Aug;124(8):3566-78. doi: 10.1172/JCI74068. Epub 2014 Jul 1.
8
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.对肝细胞腺瘤的基因组分析揭示了 FRK 激活突变的重现和恶性转化的机制。
Cancer Cell. 2014 Apr 14;25(4):428-41. doi: 10.1016/j.ccr.2014.03.005.
9
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.表皮生长因子受体抑制可减轻肝纤维化和肝癌的发展。
Hepatology. 2014 Apr;59(4):1577-90. doi: 10.1002/hep.26898. Epub 2014 Feb 28.
10
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.鉴定依赖自分泌 IL-6 信号促进恶性进展的肝癌祖细胞。
Cell. 2013 Oct 10;155(2):384-96. doi: 10.1016/j.cell.2013.09.031.

肝癌的发生需要 CD44 增强的生长因子信号抑制 p53。

Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.

机构信息

Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California San Diego, School of Medicine, 9500 Gilman Drive, San Diego, CA 92093, USA.

Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California San Diego, School of Medicine, 9500 Gilman Drive, San Diego, CA 92093, USA; Department of Gastroenterology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

出版信息

Cancer Cell. 2018 Jun 11;33(6):1061-1077.e6. doi: 10.1016/j.ccell.2018.05.003.

DOI:
10.1016/j.ccell.2018.05.003
PMID:29894692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6005359/
Abstract

How fully differentiated cells that experience carcinogenic insults become proliferative cancer progenitors that acquire multiple initiating mutations is not clear. This question is of particular relevance to hepatocellular carcinoma (HCC), which arises from differentiated hepatocytes. Here we show that one solution to this problem is provided by CD44, a hyaluronic acid receptor whose expression is rapidly induced in carcinogen-exposed hepatocytes in a STAT3-dependent manner. Once expressed, CD44 potentiates AKT activation to induce the phosphorylation and nuclear translocation of Mdm2, which terminates the p53 genomic surveillance response. This allows DNA-damaged hepatocytes to escape p53-induced death and senescence and respond to proliferative signals that promote fixation of mutations and their transmission to daughter cells that go on to become HCC progenitors.

摘要

细胞在经历致癌因素后是如何完全分化成为具有增殖能力的肿瘤祖细胞,并获得多个起始突变的,目前尚不清楚。这个问题对于肝癌(HCC)尤为重要,因为 HCC 起源于分化的肝细胞。本文中,我们发现 CD44 提供了一种解决方案,CD44 是透明质酸受体,其表达可被 STAT3 依赖性方式快速诱导至暴露于致癌剂的肝细胞中。一旦表达,CD44 就会增强 AKT 的激活,从而诱导 Mdm2 的磷酸化和核转位,从而终止 p53 基因组监测反应。这使得受损的肝细胞能够逃避 p53 诱导的死亡和衰老,并对促进突变固定及其传递给继续成为 HCC 祖细胞的子细胞的增殖信号做出反应。